Evidence map›Paper›PMID 33377530›Full record

ArticleBioEssays : news and reviews in molecular, cellular and developmental biology2021

Fighting microbial pathogens by integrating host ecosystem interactions and evolution.

Alita R Burmeister, Elsa Hansen, Jessica J Cunningham, E Hesper Rego, Paul E Turner, Joshua S Weitz, Michael E Hochberg

Open access · hybridAbstract read
In one paragraph

Article in BioEssays : news and reviews in molecular, cellular and developmental biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Anti-infective compounds forSustainable microbiology · 2026
    Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Alita R BurmeisterDepartment of Ecology and Evolutionary Biology, Yale University, New Haven, Connecticut, USA.ORCID 0000-0003-4304-5551
Elsa HansenDepartment of Biology, Center for Infectious Disease Dynamics, Pennsylvania State University, University Park, Pennsylvania, USA.ORCID 0000-0003-1874-529X
Jessica J CunninghamDepartment of Integrated Mathematical Oncology, Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.ORCID 0000-0001-8704-8848
E Hesper RegoDepartment of Microbial Pathogenesis, Yale University School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0002-2973-8354
Paul E TurnerDepartment of Ecology and Evolutionary Biology, Yale University, New Haven, Connecticut, USA.ORCID 0000-0003-3490-7498
Joshua S WeitzSchool of Biological Sciences, Georgia Institute of Technology, Atlanta, Georgia, USA.ORCID 0000-0002-3433-8312
Michael E HochbergInstitute of Evolutionary Sciences, University of Montpellier, Montpellier, France.ORCID 0000-0002-6774-5213
Yale University · USGeorgia Institute of Technology · USMoffitt Cancer Center · USPennsylvania State University · USSanta Fe Institute · US

Funding

The Physi(ologi)cal Microenvironment and its Role in Tumor Invasion and MetastaseU54CA143970 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI GATENBY, ROBERT A · 2009 to 2014
$9.3M
Synergistic control of acute respiratory pathogens by bacteriophage and the innate immune responseR01AI146592 · NIAID · UNIV OF MARYLAND, COLLEGE PARK · PI DEBARBIEUX, LAURENT, WEITZ, JOSHUA · 2019 to 2023
$2.4M
Application of Evolutionary Principles to Maintain Cancer Control (PQ21)R01CA170595 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI GATENBY, ROBERT A · 2012 to 2015
$2.1M
Understanding the genetic, evolutionary, and ecological interactions between drug resistance and phage resistanceR21AI144345 · NIAID · YALE UNIVERSITY · PI BURMEISTER, ALITA, TURNER, PAUL E · 2019 to 2020
$441k
NCI NIH HHS R01 CA170595NCI NIH HHS U54 CA143970NIAID NIH HHS R01 AI146592NIAID NIH HHS R21 AI144345NIH HHS 1R01AI46592-01NIH HHS R01CA17059NIH HHS R21AI144345NIH HHS U54CA143970-05
6 · The paper itself

Abstract

Successful therapies to combat microbial diseases and cancers require incorporating ecological and evolutionary principles. Drawing upon the fields of ecology and evolutionary biology, we present a systems-based approach in which host and disease-causing factors are considered as part of a complex network of interactions, analogous to studies of "classical" ecosystems. Centering this approach around empirical examples of disease treatment, we present evidence that successful therapies invariably engage multiple interactions with other components of the host ecosystem. Many of these factors interact nonlinearly to yield synergistic benefits and curative outcomes. We argue that these synergies and nonlinear feedbacks must be leveraged to improve the study of pathogenesis in situ and to develop more effective therapies. An eco-evolutionary systems perspective has surprising and important consequences, and we use it to articulate areas of high research priority for improving treatment strategies.

Indexed as

Biological EvolutionEcosystemcancerinfectious diseasenonlinear dynamicsresistancesystems approachtherapies

Identifiers

PMID33377530
PMCPMC9127240
OpenAlexW3115940839

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.